THIS END UP DEPAKOTE SPRINKLE 125MG Pill - blue white capsule/oblong

Pill with imprint THIS END UP DEPAKOTE SPRINKLE 125MG is Blue / White, Capsule/Oblong and has been identified as Divalproex sodium delayed-release (sprinkle) 125 mg. It is supplied by Sandoz Inc.

Divalproex sodium is used in the treatment of Bipolar Disorder; Mania; Migraine Prevention; Seizures; Epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for THIS END UP DEPAKOTE SPRINKLE 125MG

Divalproex sodium delayed-release (sprinkle) 125 mg THIS END UP DEPAKOTE SPRINKLE 125MG

Divalproex sodium delayed-release (sprinkle)

Imprint: THIS END UP DEPAKOTE SPRINKLE 125MG
Strength: 125 mg
Color: Blue / White
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule: Not a controlled drug
Labeler / Supplier: Sandoz Inc.
Inactive Ingredients: silicon dioxide, triethyl citrate, magnesium stearate, gelatin, D&C Red No. 28, FD&C Blue No. 1, ferric oxide red, titanium dioxide
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00074-6114	Abbott Laboratories
00781-2243 (Discontinued)	Sandoz Inc.
49999-0942	Lake Erie Medical and Surgical Supply (repackager)
55289-0991	PDRX Pharmaceuticals Inc. (repackager)